Smilegate Youth Start-up Fund managed by Smilegate Youth Start-up Fund acquired 3.33% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.4 billion.
April 03, 2015 at 09:30 am IST
Share
Smilegate Youth Start-up Fund managed by Smilegate Youth Start-up Fund acquired 3.33% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.4 billion on March 30, 2015. Psoma Therapeutics, Inc. sold 0.06 million shares at the price of KRW 25,000 per share and reduced its holding to 0.07 million shares.
Smilegate Youth Start-up Fund managed by Smilegate Youth Start-up Fund completed the acquisition of 3.33% stake in MG MED, Inc. from Psoma Therapeutics, Inc. on March 30, 2015.
Dx & Vx Co Ltd, formerly Cancer Rop Co Ltd, is a Korea-based company primarily engaged in the molecular diagnosis business. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.
Smilegate Youth Start-up Fund managed by Smilegate Youth Start-up Fund acquired 3.33% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.4 billion.
DX & VX CO., LTD. 
